Ruihua Dong

7PUBLICATIONS
7CO-AUTHORS
Gene and molecular therapyPredictive and prognostic markersPharmaceutical delivery technologiesApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Political economy and social change
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jun 25, 2026
Drug Interactions of Vebreltinib, a Novel Type I c-Met Inhibitor, Coadministration With Rifampin or Itraconazole in Healthy Participants.

|May 08, 2026
Unravelling the human disposition of [14C]-vebreltinib: Faecal recovery of parent drug and a major circulating metabolite defines its mass balance profile.

|Mar 18, 2026
The Molecular Interplay Between Helicobacter pylori Infection and Ulcerative Colitis: Unraveling Shared Biomarkers and Pathway Networks.

Min Zhu, Xiao Li, Xinyuan Huang

|Mar 22, 2025
Trends in drug-drug interactions for new drug clinical trials in China over the past 10 years (2013-2022).

Jianxiong Zhang, Jingxuan Wu, Jiangshuo Li

|Sep 17, 2024
Immunothrombosis: A bibliometric analysis from 2003 to 2023.

Mengyu Hou, Jingxuan Wu, Jiangshuo Li

|Sep 12, 2024
Changes in Early-Phase Clinical Trials in China During 2013-2022: A Review.

Jianxiong Zhang, Peng Zhang, Haixue Wang

Pageof 2

Frequent Collaborators

2 joint publications

Jingcheng Chen

2 joint publications

Lijun Li

1 joint publications

Min Zhu

1 joint publications

Shutian Zhang